JP2020532551A - Ｒｈｏ関連コイルドコイルキナーゼ（ＲＯＣＫ）阻害剤としてのビニルヘテロ環 - Google Patents

Ｒｈｏ関連コイルドコイルキナーゼ（ＲＯＣＫ）阻害剤としてのビニルヘテロ環 Download PDF

Info

Publication number
JP2020532551A
JP2020532551A JP2020512687A JP2020512687A JP2020532551A JP 2020532551 A JP2020532551 A JP 2020532551A JP 2020512687 A JP2020512687 A JP 2020512687A JP 2020512687 A JP2020512687 A JP 2020512687A JP 2020532551 A JP2020532551 A JP 2020532551A
Authority
JP
Japan
Prior art keywords
vinyl
isoindoline
bipyrimidine
pyridin
pyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020512687A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020532551A5 (https=
Inventor
リー、アン−フ
ダナ、ディビエンドゥ
リム、ドンサン
ガディーヤ、サティシュクマール
ジュン、ダウン
ナラヤン、プラカシュ
アリ、クエーサー
パカ、ラタ
ゴールドバーグ、イツァーク・ディー
Original Assignee
アンジオン バイオメディカ コーポレーション
アンジオン バイオメディカ コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アンジオン バイオメディカ コーポレーション, アンジオン バイオメディカ コーポレーション filed Critical アンジオン バイオメディカ コーポレーション
Publication of JP2020532551A publication Critical patent/JP2020532551A/ja
Publication of JP2020532551A5 publication Critical patent/JP2020532551A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2020512687A 2017-09-03 2018-08-31 Ｒｈｏ関連コイルドコイルキナーゼ（ＲＯＣＫ）阻害剤としてのビニルヘテロ環 Pending JP2020532551A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762553885P 2017-09-03 2017-09-03
US62/553,885 2017-09-03
PCT/US2018/049225 WO2019046795A1 (en) 2017-09-03 2018-08-31 VINYL HETEROCYCLES AS INHIBITORS OF RHO (ROCK) ASSOCIATED BISPIRALIZED KINASE

Publications (2)

Publication Number Publication Date
JP2020532551A true JP2020532551A (ja) 2020-11-12
JP2020532551A5 JP2020532551A5 (https=) 2021-10-14

Family

ID=65526110

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020512687A Pending JP2020532551A (ja) 2017-09-03 2018-08-31 Ｒｈｏ関連コイルドコイルキナーゼ（ＲＯＣＫ）阻害剤としてのビニルヘテロ環

Country Status (8)

Country Link
US (1) US11542256B2 (https=)
EP (1) EP3676262A4 (https=)
JP (1) JP2020532551A (https=)
CN (1) CN111406051A (https=)
AU (1) AU2018326785B2 (https=)
CA (1) CA3073956A1 (https=)
IL (1) IL272939A (https=)
WO (1) WO2019046795A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025515296A (ja) * 2022-04-20 2025-05-14 シャンハイ ジムン バイオファーマ，インコーポレーテッド Ｒｈｏ関連プロテインキナーゼ阻害剤ならびにその調製および応用

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11542256B2 (en) 2017-09-03 2023-01-03 Angion Biomedica Corp. Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors
EP4003340A4 (en) * 2019-07-22 2023-09-27 Angion Biomedica Corp. ETHYNYL HETEROCYCLES AS RHO-ASSOCIATED BISPIRAL KINASE (ROCK) INHIBITORS
TW202132285A (zh) * 2019-11-13 2021-09-01 美商愛彼特生物製藥股份有限公司 經取代異吲哚啉基2,2’-聯嘧啶基化合物、其類似物及使用其之方法
CA3189725A1 (en) * 2020-07-21 2022-01-27 Angion Biomedica Corp. Inhibitors of rho-associated coiled-coil kinase
US12600722B2 (en) 2022-07-18 2026-04-14 Incyte Corporation Tetracyclic compounds as DGK inhibitors
US12600723B2 (en) 2022-07-18 2026-04-14 Incyte Corporation Tetracyclic compounds as DGK inhibitors

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003531112A (ja) * 1999-12-22 2003-10-21 メルク フロスト カナダ アンド カンパニー 置換８−アリールキノリン系ホスホジエステラーゼ−４阻害薬
JP2008509175A (ja) * 2004-08-13 2008-03-27 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング １，５−ジフェニルピラゾール
WO2008120810A1 (ja) * 2007-03-29 2008-10-09 Sumitomo Chemical Company, Limited 化合物、光電変換素子及び光電気化学電池
JP2010501003A (ja) * 2006-08-16 2010-01-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ピラジン化合物、その使用及び調製方法
JP2010504295A (ja) * 2006-09-21 2010-02-12 ノバルティス アーゲー サイトカイン介在疾患の処置に有用なピロール誘導体
WO2011011312A1 (en) * 2009-07-22 2011-01-27 Merck Sharp & Dohme Corp. Quinolinone pde2 inhibitors
WO2013089087A1 (ja) * 2011-12-15 2013-06-20 富士フイルム株式会社 光電変換素子及び色素増感太陽電池
WO2015190467A1 (ja) * 2014-06-11 2015-12-17 富士フイルム株式会社 光電変換素子、色素増感太陽電池、金属錯体色素、色素溶液、およびターピリジン化合物またはそのエステル化物

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5322756A (en) * 1992-07-09 1994-06-21 Xerox Corporation Magnetic fluids and method of preparation
EP1490362A2 (en) 2001-03-08 2004-12-29 Millennium Pharmaceuticals, Inc. (homo)piperazine substituted quinolines for inhibiting the phosphorylation of kinases
CR9465A (es) 2005-03-25 2008-06-19 Surface Logix Inc Compuestos mejorados farmacocineticamente
US7758972B2 (en) * 2006-09-26 2010-07-20 Semiconductor Energy Laboratory Co., Ltd. Stilbene derivative, light emitting element, light emitting device, and electronic appliance
WO2008054599A2 (en) 2006-09-27 2008-05-08 Surface Logix, Inc. Rho kinase inhibitors
EP2116522B1 (en) * 2007-02-28 2013-09-18 JNC Corporation Pentacyclic liquid crystal compound having cf<sb>2</sb>o bonding group, liquid crystal composition and liquid crystal display
US20120202793A1 (en) 2009-03-09 2012-08-09 Paul Sweetnam Rho kinase inhibitors
EP2542528B1 (en) 2010-03-02 2013-06-19 Amakem NV Heterocyclic amides as rock inhibitors
WO2012040499A2 (en) 2010-09-22 2012-03-29 Surface Logix, Inc. Metabolic inhibitors
CN113620933A (zh) 2012-10-05 2021-11-09 卡德门企业有限公司 Rho激酶抑制剂
WO2014093773A1 (en) 2012-12-14 2014-06-19 The Brigham And Women's Hospital, Inc. Methods and assays relating to macrophage differentiation
PT2951172T (pt) 2013-01-29 2017-07-12 Redx Pharma Plc Derivados de piridina como inibidores de rock leves
US11311541B2 (en) 2014-04-09 2022-04-26 Kadmon Corporation, Llc Treatment of GVHD
US9902702B2 (en) * 2014-07-15 2018-02-27 Bristol-Myers Squibb Company Spirocycloheptanes as inhibitors of rock
US10011600B2 (en) 2014-09-25 2018-07-03 Araxes Pharma Llc Methods and compositions for inhibition of Ras
WO2016081554A1 (en) 2014-11-18 2016-05-26 Neostem Oncology, Llc Immunogenic compositions prepared from tumor cells derived from peripheral blood and originating from a solid tumor and their use
JP2018501276A (ja) 2015-01-09 2018-01-18 ギリアド アポロ， エルエルシー 非アルコール性脂肪肝疾患の処置のためのａｃｃ阻害剤併用療法
US9687483B2 (en) 2015-01-26 2017-06-27 BioAxone BioSciences, Inc. Treatment of cerebral cavernous malformations and cerebral aneurysms with Rho kinase inhibitors
US10106525B2 (en) 2015-01-26 2018-10-23 BioAxone BioSciences, Inc. Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
US10149856B2 (en) 2015-01-26 2018-12-11 BioAxone BioSciences, Inc. Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
ES2730112T3 (es) 2015-03-09 2019-11-08 Bristol Myers Squibb Co Lactamas como inhibidores de ROCK
KR20180021741A (ko) 2015-05-29 2018-03-05 에쥐 세라피틱스, 인코포레이티드 시각 손실을 감소시키기 위한 조성물 및 방법
DK3312270T3 (da) 2015-06-16 2020-10-12 Univ Kyoto Fremgangsmåde til fremstilling af plader med høj ydeevne
AU2017246228B2 (en) 2016-04-04 2021-04-15 Chemocentryx, Inc. Soluble C5aR antagonists
JP2019112307A (ja) 2016-04-28 2019-07-11 宇部興産株式会社 置換ジヒドロピロロピラゾール化合物および他の乾癬治療薬が組み合わせて投与される医薬組成物
SG11201810602YA (en) 2016-06-03 2018-12-28 Chemocentryx Inc Method of treating liver fibrosis
CN107019698A (zh) 2016-08-04 2017-08-08 上海市第十人民医院 Rock2抑制剂在制备炎症性肠病药物中的应用
WO2018052953A1 (en) 2016-09-13 2018-03-22 President And Fellows Of Harvard College Methods relating to intestinal organ-on-a-chip
KR101892154B1 (ko) 2017-02-22 2018-08-28 한국과학기술연구원 Ｒｈｏ-연관된 단백질 키나제 저해제를 포함하는 면역 반응 증강용 조성물 및 이를 이용한 방법
CN106916145B (zh) 2017-03-06 2019-06-04 上海应用技术大学 SLx-2119的合成方法
KR20190122806A (ko) 2017-03-13 2019-10-30 장피트 조합 치료요법용 약학 조성물
AU2018234059A1 (en) 2017-03-16 2019-10-31 Takeda Gmbh Treatment of idiopathic pulmonary fibrosis
CN110536682B (zh) 2017-04-18 2023-01-06 基恩菲特公司 依拉非诺或其衍生物与抗nash、抗纤维化或抗胆汁淤积药剂的组合
US11541046B2 (en) 2017-06-30 2023-01-03 Quixgen, Inc. Spirolactone compounds
US11542256B2 (en) 2017-09-03 2023-01-03 Angion Biomedica Corp. Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors
GB201715930D0 (en) 2017-09-30 2017-11-15 Upside Biotechnologies Ltd Cell Culture Medium
GB201715928D0 (en) 2017-09-30 2017-11-15 Auckland Uniservices Ltd Method
KR20200109298A (ko) 2017-10-30 2020-09-22 케모센트릭스, 인크. 면역조절제로서의 중수소화된 화합물
WO2019099457A1 (en) 2017-11-14 2019-05-23 Quixgen, Inc. Benzodioxinone compounds
HRP20241643T1 (hr) 2017-12-06 2025-02-14 Basf As Derivati masnih kiselina za liječenje nealkoholnog steatohepatitisa
MX2020006460A (es) 2017-12-22 2020-11-06 Chemocentryx Inc Compuestos de anillo 5,5 fusionado sustituido con diarilo como inhibidores de c5ar.
ES2980175T3 (es) 2017-12-22 2024-09-30 Chemocentryx Inc Compuestos anulares fusionados en 6,5 sustituidos con diarilo como inhibidores de C5aR
WO2019195159A1 (en) 2018-04-02 2019-10-10 Chemocentryx, Inc. PRODRUGS OF FUSED-BICYCLIC C5aR ANTAGONISTS
US20190328721A1 (en) 2018-04-25 2019-10-31 Korea Institute Of Science And Technology Method of activating dendritic cells
CN110200972A (zh) 2019-05-10 2019-09-06 南京市儿童医院 Kd025在制备防治慢性肾纤维化的药物中的用途
EP4003340A4 (en) 2019-07-22 2023-09-27 Angion Biomedica Corp. ETHYNYL HETEROCYCLES AS RHO-ASSOCIATED BISPIRAL KINASE (ROCK) INHIBITORS
CA3189725A1 (en) 2020-07-21 2022-01-27 Angion Biomedica Corp. Inhibitors of rho-associated coiled-coil kinase

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003531112A (ja) * 1999-12-22 2003-10-21 メルク フロスト カナダ アンド カンパニー 置換８−アリールキノリン系ホスホジエステラーゼ−４阻害薬
JP2008509175A (ja) * 2004-08-13 2008-03-27 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング １，５−ジフェニルピラゾール
JP2010501003A (ja) * 2006-08-16 2010-01-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ピラジン化合物、その使用及び調製方法
JP2010504295A (ja) * 2006-09-21 2010-02-12 ノバルティス アーゲー サイトカイン介在疾患の処置に有用なピロール誘導体
WO2008120810A1 (ja) * 2007-03-29 2008-10-09 Sumitomo Chemical Company, Limited 化合物、光電変換素子及び光電気化学電池
WO2011011312A1 (en) * 2009-07-22 2011-01-27 Merck Sharp & Dohme Corp. Quinolinone pde2 inhibitors
WO2013089087A1 (ja) * 2011-12-15 2013-06-20 富士フイルム株式会社 光電変換素子及び色素増感太陽電池
WO2015190467A1 (ja) * 2014-06-11 2015-12-17 富士フイルム株式会社 光電変換素子、色素増感太陽電池、金属錯体色素、色素溶液、およびターピリジン化合物またはそのエステル化物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JONNATAN J. SANTOS ET AL.: "Exploring the coordination chemistry of isomerizable terpyridine derivatives for successful analyses", ANALYST, vol. 137, JPN6022031874, 18 June 2012 (2012-06-18), pages 4045 - 4051, ISSN: 0005210625 *
KEVIN QINA ET AL.: "Hit to Lead Account of the Discovery of a New Class of Inhibitors of Pim Kinase and Crystallographic", JOURNAL OF MEDICINAL CHEMISTRY, vol. 52, JPN6022031873, 3 March 2009 (2009-03-03), US, pages 1814 - 1827, ISSN: 0005210624 *
YAN ZHANG ET AL.: "Switchable sensitizers stepwise lighting up lanthanide emissions", SCIENTIFIC REPORTS, vol. 5, no. 9335, JPN6022031875, 20 March 2015 (2015-03-20), pages 1 - 5, ISSN: 0005210626 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025515296A (ja) * 2022-04-20 2025-05-14 シャンハイ ジムン バイオファーマ，インコーポレーテッド Ｒｈｏ関連プロテインキナーゼ阻害剤ならびにその調製および応用

Also Published As

Publication number Publication date
IL272939A (en) 2020-04-30
CN111406051A (zh) 2020-07-10
CA3073956A1 (en) 2019-03-07
EP3676262A1 (en) 2020-07-08
AU2018326785A1 (en) 2020-04-09
WO2019046795A1 (en) 2019-03-07
US11542256B2 (en) 2023-01-03
AU2018326785B2 (en) 2023-03-02
EP3676262A4 (en) 2021-03-31
US20200231576A1 (en) 2020-07-23

Similar Documents

Publication Publication Date Title
JP2020532551A (ja) Ｒｈｏ関連コイルドコイルキナーゼ（ＲＯＣＫ）阻害剤としてのビニルヘテロ環
JP6152389B2 (ja) 抗線維化化合物及びその使用
TWI600638B (zh) 作爲蛋白質去乙醯酶抑制劑之反式醯胺化合物及其使用方法
JP5775452B2 (ja) 肝細胞増殖因子（分散因子）活性の低分子モジュレーターの組成物および方法
JP2010529134A (ja) 複素環化合物およびその使用
CN1747730B (zh) 肝细胞生长因子(分散因子)活性的吡唑衍生物调节剂
JP6855636B2 (ja) イミダゾリジン化合物
JP2022541829A (ja) Ｒｈｏ関連コイルドコイルキナーゼ（ＲＯＣＫ）阻害剤としてのエチニルヘテロ環
AU2020257075B2 (en) Methods and agents for treating disease
TW202110833A (zh) 新穎環狀緩激肽b2受體拮抗劑
CN116209658A (zh) Rho相关卷曲螺旋激酶的抑制剂
JP2021503442A (ja) 中枢および末梢神経系障害の治療のためのキナーゼ阻害剤
US9597321B2 (en) Antifibrotic compounds and uses thereof
CN120303249A (zh) 碳酸酐酶抑制剂及其使用方法
US20110098304A1 (en) Small molecule inhibitors of PARP activity
CN103319408B (zh) 用于预防和治疗心血管疾病的化合物
CA3223869A1 (en) Compositions for the treatment of hypertension and/or fibrosis
HK40021008A (en) Anti-fibrotic compounds and uses thereof
HK1203502B (zh) 抗纤维化的化合物及其用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210824

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210824

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220726

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220802

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220810

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221027

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20221228

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230202

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230516

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20231205